按品牌選擇
|
|
|||||||||||||||||||||||||||||||||
| [發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] | ||||||||||||||||||||||||||||||||||
| 銷售商： 北京啟維益成科技有限公司 | 查看該公司所有產(chǎn)品 >> |
| Catalogue Number | HOR-282 |
| Description | Lanreotide is a peptide inhibitor of a number of endocrine, neuroendocrine, exocrine and paracrine functions. It shows good affinity for peripheral somatostatin receptors (anterior pituitary and pancreatic). In contrast, its affinity for central receptors is much lower. This profile confers a good specificity of action at the level of growth hormone and digestive hormone secretion. Lanreotide shows a much longer duration of action than natural somatostatin. In addition, its marked selectivity for the secretion of growth hormone, compared to that of insulin, makes it a suitable candidate for the treatment of acromegaly. By inhibiting the synthesis of thyroid stimulating hormone (TSH), lanreotide also normalised thyroid function of patients with thyrotrophin secreting adenomas in 50% (8/16) of the per-protocol population treated for 6 months. There was no significant reduction in the size of the adenoma. Furthermore, the inhibitory action of lanreotide on intestinal exocrine secretion, digestive hormones and cellular proliferation mechanisms is suited to the symptomatic treatment of endocrine digestive tumours, especially carcinoids. Lanreotide is an octapeptide, an analogue of a naturally occurring hormone, somatostatin. Lanreotide lowers the levels of hormones in the body such as GH (growth hormone) and IGF-1 (insulin-like growth factor-1) and inhibits some digestive hormones and intestinal secretions. |
| Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Formulation | The protein (1 mg/ml) was lyophilized with 5 mg manntitol and 0.04 mg tween-80. |
| Solubility | It is recommended to reconstitute the lyophilized Lanreotide in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
| Stability | Lyophilized Lanreotide although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Lanreotide should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
| Purity | Greater than 99.0% as determined by(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
| Usage | Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
手機(jī)版：Lanreotide
- 中喬新舟限時(shí)促銷：買細(xì)胞就送支原體檢測(cè)試劑盒
- 華威中儀試劑盒年末限時(shí)優(yōu)惠來襲，儲(chǔ)值享好禮
- 美德聲推出新品重組細(xì)胞系用于生產(chǎn)單克隆血型試劑
- 百螢小麥胚芽凝集素探針染料8折優(yōu)惠，買即贈(zèng)鼠標(biāo)墊
- 上海惠誠(chéng)生物成為安普未來恒溫?cái)U(kuò)增試劑盒代理商
- 雙11科研狂歡促銷，逐典攜手埃澤思下單滿額雙重好禮
- MCE 第三屆細(xì)胞攝影大賽圓滿落幕，評(píng)選結(jié)果公布
- MCE教師節(jié)直播:細(xì)胞凋亡的機(jī)制、標(biāo)志物與檢測(cè)方法
- 大鼠肺泡巨噬細(xì)胞(NR8383)培養(yǎng)要點(diǎn)
- 干細(xì)胞誘導(dǎo)生成類器官的工藝要點(diǎn)淺析
- 細(xì)胞復(fù)蘇的原理、實(shí)驗(yàn)步驟及注意事項(xiàng)
- 10個(gè)獲批干細(xì)胞新藥IND及細(xì)胞療法應(yīng)用案例分享
- 寵物干細(xì)胞行業(yè)技術(shù)服務(wù)體系及在治療中的應(yīng)用
- 《人臍帶間充質(zhì)干細(xì)胞治療膝骨性關(guān)節(jié)炎臨床應(yīng)用指南》內(nèi)容及適用范圍
- 免疫B細(xì)胞的分類、活化機(jī)制、主要功能及在疾病治療中的應(yīng)用
- 自然殺傷細(xì)胞（NK細(xì)胞）的功能及培養(yǎng)流程
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com